BOT 6.25% 34.0¢ botanix pharmaceuticals ltd

Ann: Botanix Receives Approval for Synthetic Cannabidiol Trial, page-7

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,381 Posts.
    lightbulb Created with Sketch. 429
    "“these studies will be the first to be conducted anywhere in the world using synthetic cannabidiol for the treatment of skin disease, with oversight from a regulator.”

    Giddy-up.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
34.0¢
Change
0.020(6.25%)
Mkt cap ! $617.9M
Open High Low Value Volume
32.5¢ 34.3¢ 32.5¢ $1.814M 5.424M

Buyers (Bids)

No. Vol. Price($)
6 489055 33.5¢
 

Sellers (Offers)

Price($) Vol. No.
34.5¢ 340303 4
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.